Clinical trials: Hand Eczema
Hand Eczema
A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema
The purpose of this study is to investigate whether a moisturizing cream can prevent hand eczema.Patients with previous hand eczema will be studied.
- Trial name
- NCT00576550
- Testing
- Urea, betamethasone valerate
- Where
- 3 sites in Norway
- Volunteers
- 53 people
- Sponsor
- ACO Hud Nordic AB
Chronic Hand Eczema
Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema
This study will assess the safety and efficacy of ARQ-252 cream in subjects with chronic hand eczema
- Trial name
- NCT04378569
- Testing
- ARQ-252 cream 0.3%, ARQ-252 cream 0.1%, ARQ-252 Vehicle Cream
- Where
- 37 sites in United States, Australia and 1 more
- Volunteers
- 230 people
- Sponsor
- Arcutis Biotherapeutics, Inc.
Hand Dermatosis
Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis
The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.
- Trial name
- NCT00828464
- Testing
- clobetasol propionate
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Stiefel, a GSK Company
Eczema
Paraffin Bath Therapy for Chronic Hand Eczema
Objective: Chronic Hand eczema (CHE) is a common inflammatory skin disease has a major medical psychological and socio-economic implications that affect quality of life (QoL)and work ability.
- Trial name
- NCT04510961
- Testing
- Paraffin baths therapy
- Where
- Saudi Arabia
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Cairo University
Hand Eczema
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease activity (Investigator's Global Assessement…
- Trial name
- TRuE-CHE1 (NCT05219864)
- Testing
- Ruxolitinib cream, Vehicle
- Where
- 49 sites in United States, Canada and 4 more
- Sponsor
- Incyte Corporation
Contact Dermatitis of Hands
The Effectiveness and Safety of Niacinamide 4% and Virgin Coconut Oil 30% for Secondary Prevention of Occupational Hand Dermatitis
Occupational hand dermatitis (OHD) often occurs in intensive care unit (ICU) nurses, especially in individuals who are vulnerable due to irritant exposure e.g. hand rub alcohol and repeated hand washing activities.
- Trial name
- NCT04218500
- Testing
- Niacinamide 4%, Virgin Coconut oil 30%
- Where
- Indonesia
- Volunteers
- 92 people
- Sponsor
- Universitas Indonesia
Hand Eczema
Hand Eczema in the Health Care Sector
This project aims to investigate the prevalence of bacterial colonization and associated factors in health care workers with hand eczema with focus on Staphylococcus aureus.
- Trial name
- NCT04449575
- Testing
- eSwabs
- Where
- Denmark
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- University Hospital Bispebjerg and Frederiksberg
Chronic Hand Eczema (CHE)
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease activity (Investigator's Global Assessement…
- Trial name
- TRuE-CHE2 (NCT05233410)
- Testing
- Ruxolitinib cream, Vehicle
- Where
- 39 sites in United States, Bulgaria and 5 more
- Sponsor
- Incyte Corporation
Hand Dermatitis
FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults
Hand dermatitis, (a rash, or eczema, on the hands) is a common skin condition that affects approximately 10% of the population. It can be caused by a wide variety of things, such as allergens or irritants.
- Trial name
- FiteBac (NCT01950494)
- Testing
- fiteBac Hand Sanitizer
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- National Jewish Health
Chronic Hand Eczema
Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)
This study is a multicentre, double-blinded, randomized, placebo-controlled, clinical trial with open-label extension. The purpose and aim of this study is to investigate the efficacy and safety of roflumilast (PDE4-inhibitor) in…
- Trial name
- NCT05682859
- Testing
- Roflumilast 500 Mcg Oral Tablet
- Where
- Denmark
- Volunteers
- 41 people
- Sponsor
- Jacob Pontoppidan Thyssen
Hand Eczema
LEO19123 Cream in the Treatment of Hand Eczema
To compare the efficacy and safety of two different dose combinations of LEO19123 cream (calcipotriol and LEO80122) with LEO19123 cream vehicle for 3 weeks in the treatment of patients with hand eczema.
- Trial name
- NCT00404196
- Testing
- Calcipotriol and LEO80122 (LEO19123 cream)
- Where
- United Kingdom
- Volunteers
- 75 people
- Sponsor
- LEO Pharma
Hand Eczema, Foot Eczema
Treatment of Staphylococcus Aureus Colonization in Hand Eczema
Atopic dermatitis is a chronic disease characterized by itching and eczematous lesions. In adults, eczema commonly localizes to the hands or feet.
- Trial name
- NCT01591785
- Testing
- Retapamulin 1% ointment
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Gary Goldenberg
Atopic Dermatitis
Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.
The purpose of this study is to investigate the comparative efficacy, safety and efficiency of ciclosporin microemulsion and alitretinoin in adults with severe atopic hand dermatitis.
- Trial name
- TocyDD (NCT01231854)
- Testing
- Ciclosporin, Alitretinoin
- Where
- Germany
- Volunteers
- 15 people
- Sponsor
- Technische Universität Dresden
Chronic Hand Eczema
Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials
The purpose of this extension trial is to evaluate the long-term safety of delgocitinib. Subjects will visit the clinic every 4 week to assess the safety and efficacy of the treatment, until Week 36.
- Trial name
- DELTA 3 (NCT04949841)
- Testing
- Delgocitinib
- Where
- 95 sites in Belgium, Canada and 8 more
- Volunteers
- 801 people
- Sponsor
- LEO Pharma
Hand Eczema
Topical Ruxolitinib Evaluation in Chronic Hand Eczema
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease activity (Investigator's Global Assessement…
- Trial name
- NCT05906628
- Testing
- Ruxolitinib cream, Vehicle
- Where
- 36 sites in United States, Canada and 2 more
- Volunteers
- 186 people
- Sponsor
- Incyte Corporation
Chronic Hand Dermatitis
Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis
This pilot, phase II, 24-week study will recruit a total of 10 patients and will evaluate the efficacy and safety of acitretin in patients with severe chronic hand dermatitis .
- Trial name
- NCT01545284
- Testing
- Acitretin
- Where
- 2 sites in Canada
- Volunteers
- 9 people
- Sponsor
- Innovaderm Research Inc.
Chronic Hand Eczema
Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema
Prospective, descriptive, multicenter, real-world, international clinical investigation. Data collection is based on current clinical practice over a 6-month follow-up period using both electronic Case Report Form (eCRF) and…
- Trial name
- CARING (NCT05545215)
- Testing
- Dexyane Med
- Sponsor
- Pierre Fabre Medicament
Atopic Dermatitis, Atopic Eczema
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
The purpose of this study is to compare the effect of video-based patient education with written instruction on subjects' knowledge of atopic dermatitis and their disease severity, measured by the Patient-oriented Eczema Measure…
- Conditions
- Atopic Dermatitis, Atopic Eczema, Infantile Eczema, Hand Eczema
- Trial name
- NCT00826592
- Testing
- Patient Educational Materials
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- University of California, Davis
Hand Dermatoses
Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis
Patients who have been treated in study protocol BAP089 may have responded to treatment, and subsequently relapsed to >75% of the baseline disease severity, will be investigated for response to further treatment with…
- Trial name
- NCT00124436
- Testing
- alitretinoin
- Where
- Germany
- Volunteers
- 300 people
- Sponsor
- Basilea Pharmaceutica
Contact Dermatitis of Hand
Crossover Study to Evaluate the Efficacy of LED in Treating the Signs of Contact/Irritant Dermatitis of the Hand
This study is intended to be a cross over study. Subjects will treat one hand while the contralateral hand acts as a control. At the end of 6 weeks the subject will be instructed to cease treatment of the test hand and commence…
- Trial name
- NCT05497921
- Testing
- handLITE LED device
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Steven Baker